ETF Copilot

ARKG vs XLV: holdings overlap, shared companies and scores

As of October 9, 2026, ARKG and XLV overlap 4.4% by weight. ARK Genomic Revolution ETF (ARKG): Genomics and biotech stocks. State Street Health Care Select Sector SPDR ETF (XLV): U.S. healthcare sector.

Updated October 9, 2026

Where XLV trades against its own history

XLV trades at 31.2 times earnings, against its own median of 25.1, and is more expensive than 90% of its own last 9 years.

What moved ARKG and XLV this week

ARKG fell 5.0% in the week to October 9, 2026. The holdings that moved it most were Twist Bioscience (−15.3%), 10X Genomics (−13.7%) and Tempus AI (−7.4%); Prime Medicine (+33.9%) pushed the other way.

XLV rose 2.8% in the week to October 9, 2026. The holdings that moved it most were Eli Lilly (+3.2%), Abbvie (+5.2%) and Moderna (+18.4%); Bristol-Myers Squibb (−3.3%) pushed the other way.

What do ARKG and XLV each hold?

What's inside ARKG: AI 13%.

59% of ARKG is its ten largest holdings.

What's inside XLV: AI 0%.

61% of XLV is its ten largest holdings.

How much do ARKG and XLV overlap? 4.4% by weight

As of October 9, 2026, ARKG and XLV overlap 4.4% by weight.

9% of ARKG is already inside XLV.

16% of XLV is already inside ARKG.

ARKG holds 33 companies and XLV holds 61; 2 are in both.

Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.

How does ETF Copilot score ARKG and XLV? 4.0 and 5.4 out of 10

As of October 9, 2026, ETF Copilot scores ARKG 4.0 out of 10 and XLV 5.4 out of 10.

They differ most on Risk: ARKG 0.2 and XLV 8.3.

The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.

ARKG vs XLV — ETF Copilot factor scores, 0–10
FactorARKGXLV
Growth8.16.1
Risk0.28.3
Quality0.16.8
Return5.24.5

XLV is the cheaper of the two at 0.08% a year

As of October 9, 2026, ARKG charges 0.75% a year and holds $2.1B in assets across 33 positions.

As of October 9, 2026, XLV charges 0.08% a year, yields 1.50% and holds $43.5B in assets across 61 positions.

ARKG vs XLV — cost, income and size
MeasureARKGXLV
Expense ratio0.75%0.08%
Dividend yield—1.50%
Assets under management$2.1B$43.5B
Holdings3361

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

Compare with similar funds

Cite this

ETF Copilot, “ARKG vs XLV holdings overlap and scores”, as of October 9, 2026.
https://etf-copilot.com/compare/arkg-vs-xlv

  1. ARK Genomic Revolution ETF (ARKG)
  2. State Street Health Care Select Sector SPDR ETF (XLV)

ETF Copilot Pro unlocks ARKG vs XLV prices and holdings.

Try Pro free →